Cryoport supports 779 clinical trials and 22 approved cell and gene therapies as of Q2 2026
The temperature-controlled supply chain provider reported Q2 revenue of $49.0 million and said four customers filed BLA/MAA applications during the quarter, with 11 more expected by year end.
SEC filing